文献速递类风湿关节炎脊柱关节炎

极早期关节炎患者队列的诊断谱与2年结局

Diagnostic spectrum and 2-year outcome in a cohort of patients with very early arthritis.
PubMed 文献 · RMD Open · 2017-12-22

挪威极早期关节炎门诊(Very Early Arthritis Clinic)开展一项为期2年的纵向观察研究,纳入关节肿胀持续时间不超过16周的炎症性关节炎(IA)成人患者。在1017例患者中,最常见的最终诊断是未分化关节炎(41.7%)、类风湿关节炎(24.1%)和反应性关节炎(18.1%);2年后,59%的患者关节炎缓解。在669例有2年随访数据的患者中,所有临床结局均显著改善(P<0.001)。

要点

  • 在极早期IA患者中,未分化关节炎是最常见的最终诊断(41.7%),类风湿关节炎不到四分之一(24.1%)。
  • 2年后59%的患者关节炎缓解,41.0%的患者疾病持续,其中32.1%使用改善病情抗风湿药(DMARD),8.9%有持续关节肿胀但未用DMARD。
  • 在有2年随访数据的患者中,疾病活动度、疼痛、疲劳、功能残疾和健康相关生活质量均显著改善(P<0.001)。

核心结论

  • 在1017例关节肿胀持续时间不超过16周的IA患者中,未分化关节炎是2年后最常见的诊断,不到四分之一被诊断为类风湿关节炎。
  • 多数患者未使用DMARD即实现关节炎缓解,所有临床参数在2年病程中均显著改善。

研究设计与样本

  • 挪威极早期关节炎门诊的2年纵向观察研究,纳入关节肿胀持续时间不超过16周的IA成人患者,排除晶体沉积、创伤、骨关节炎和感染性关节炎所致关节炎。
  • 对所有具有任何随访信息的患者(人群A,n=1017)描述临床诊断与关节炎持续性;对具有2年随访的患者(人群B,n=669)另评估疾病活动度、疼痛、疲劳、功能残疾和健康相关生活质量等结局。

主要发现

  • 人群A(n=1017)关节肿胀持续时间中位数(第25-75百分位)为35.0(13.0-66.5)天,平均(SD)年龄45.7(14.8)岁,女性占55.2%,抗瓜氨酸化蛋白抗体阳性占17.8%。
  • 人群A最常见的最终诊断为未分化关节炎(41.7%)、类风湿关节炎(24.1%)和反应性关节炎(18.1%)。
  • 2年后59%的患者关节炎缓解;其余41.0%为持续性疾病,其中32.1%因使用DMARD、8.9%因持续关节肿胀但未用DMARD。
  • 人群B(n=669)所有临床结局均显著改善(P<0.001);基线关节疼痛和疲劳在各诊断间相似。

关键数值与推荐

  • 关节炎持续性的定义:使用DMARD(32.1%)或未用DMARD但持续关节肿胀(8.9%),合计41.0%。
  • 人群B所有临床结局改善的显著性为P<0.001。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To describe the diagnostic spectrum, arthritis persistency and clinical outcomes after 2 years in patients with inflammatory arthritis (IA) of less than 16 weeks' duration. METHODS: Data from the Norwegian Very Early Arthritis Clinic, a 2-year longitudinal observational study of adults with IA of ≤16 weeks' duration, were used. Exclusion criteria were arthritis due to crystal deposits, trauma, osteoarthritis and septic arthritis. In all patients who had any follow-up information (population A), clinical diagnoses and persistency of arthritis were described. For patients with 2-year follow-up (population B), we also studied other clinical outcomes (disease activity, pain, fatigue, functional disability and health-related quality of life). RESULTS: In population A (n=1017) median (25th-75th percentile) duration of joint swelling was 35.0 (13.0-66.5) days, mean (SD) age 45.7 (14.8) years, 55.2% were females and 17.8% anticitrullinated protein antibodies positive. The most common final diagnoses were undifferentiated arthritis (UA) (41.7%), rheumatoid arthritis (RA) (24.1%) and reactive arthritis (18.1%). After 2 years, the arthritis had resolved in 59% of the patients. The remaining 41.0% had persistent disease defined by disease modifying antirheumatic drug (DMARD) use (32.1%) or persistent joint swelling without DMARD use (8.9%). In population B (n=669), all clinical outcomes improved significantly (P<0.001). Baseline joint pain and fatigue were similar across diagnoses. CONCLUSIONS: Among 1017 patients with IA of ≤16 weeks' duration, UA was the most common diagnosis after 2 years, and less than one-fourth were diagnosed with RA. Arthritis resolved without DMARDs in the majority of the patients. All clinical parameters improved significantly over a 2-year course.

来源:RMD Open,查看原文。版权归原作者所有。

引用

  1. Norli ES, Brinkmann GH, Kvien TK, et al. Diagnostic spectrum and 2-year outcome in a cohort of patients with very early arthritis. RMD Open. 2017. PMID: 29299343. doi:10.1136/rmdopen-2017-000573

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。